
About company
The CADASIL Eradication Project is dedicated to supporting scientific research that will lead to successful therapies for those living with CADASIL and to the eventual eradication of the CADASIL disorder altogether. What is CADASIL? CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is the most common form of hereditary stroke disorder, and is thought to be caused by mutations of the Notch 3 gene on chromosome 19. Symptoms usually begin between the ages of 40 and 50. Those who have the genetic mutation are 100% likely to suffer the symptoms that lead to early neurological degeneration and premature death, though the severity and exact manifestation of symptoms vary from person to person.